To determine cellular pathways in high-risk neuroblastoma (generally, tumors with MYCN amplification or those that have metastasized in children >18 months of age at diagnosis), we analyzed the 3000 genes most differentially expressed between low- and high-risk neuroblastomas among 498 primary neuroblastoma samples (29). Here, MYCN is linked to neuroblastoma.